Order results by:
| Issue | Title | |
| Vol 8, No 3 (2015) | COMPARATIVE PHARMACOECONOMIC STUDY OF VITAMIN-MINERAL COMPLEXES FOR REHABILITATION DURING THE PERIOD OF INCREASED NEEDS FOR MICRONUTRIENTS | Abstract similar documents |
| A. Yu. Belinskaya, I. Yu. Torshin, T. R. Grishina, O. A. Gromova | ||
| "... Objective. To conduct a pharmacoeconomic analysis is required to select an optimal vitamin ..." | ||
| Vol 15, No 1 (2022) | Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation | Abstract similar documents |
| T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg | ||
| "... in accordance with general reimbursement price asserted in the high technology medical care list part 2 (HТMC 2 ..." | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price | Abstract similar documents |
| D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov | ||
| "... as indicated, taking into consideration the new registered price. Material and methods. A clinical-economic ..." | ||
| Vol 10, No 2 (2017) | COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS | Abstract similar documents |
| M. B. Kubaeva, Y. Sh. Guchshina | ||
| "... The aim of our study was to conduct a pharmacoeconomic and cost analysis of the therapeutic use ..." | ||
| Vol 7, No 3 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA | Abstract similar documents |
| A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova | ||
| "... . Pharmacoeconomic analysis of application of oxaliplatin in colorectal cancer was performed. Cost-effectiveness ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic study of active psoriatic arthritis treatment | Abstract similar documents |
| A. V. Rudakova, Т. V. Korotaeva | ||
| "... retail prices, inclusive of value-added tax. In case of availability of biosimilars/generics ..." | ||
| Vol 14, No 2 (2021) | Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis | Abstract similar documents |
| A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova | ||
| "... years. The calculation was based on the registered prices and VAT. If there was an original drug ..." | ||
| Vol 5, No 3 (2012) | PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET | Abstract similar documents |
| R. I. Yagudina, V. G. Serpik | ||
| "... Abstract: the pharmacoeconomic study compared the standard drug therapy (vitamin D ..." | ||
| Vol 11, No 4 (2018) | Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer | Abstract similar documents |
| N. A. Avxentyev, A. S. Makarov, M. Yu. Frolov | ||
| "... patients in Russia. The aim of the current study was to develop a pharmacoeconomic tool that calculates ..." | ||
| Vol 11, No 3 (2018) | Economic barriers restraining the production of therapeutic recombinant human trypsin. Use of innovative technologies to overcome them | Abstract similar documents |
| S. V. Ponomarenko | ||
| "... the medical use of recombinant trypsin is slowed by its very high price and insufficient production ..." | ||
| Vol 10, No 2 (2017) | PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY | Abstract similar documents |
| A. V. Rudakova, S. A. Protsenko, I. A. Koroleva | ||
| "... of treatment (in the basic version) is 5.7% lower than that for nivolumab. When prices vary within reasonable ..." | ||
| Vol 11, No 3 (2018) | Pharmacoeconomic analysis of using belimumab for the treatment of systemic lupus erythematosus | Abstract similar documents |
| A. G. Tolkushin, N. L. Pogudina | ||
| "... from analysis of published clinical and observational studies. The prices of the relevant drugs were ..." | ||
| Vol 17, No 4 (2024) | Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system | Abstract similar documents |
| A. V. Rudakova, I. Z. Gaydukova | ||
| "... to the registered maximum retail prices, inclusive of value-added tax. In case of availability of biosimilars ..." | ||
| Vol 16, No 2 (2023) | Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic | Abstract similar documents |
| Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham | ||
| "... funding in the Syrian Arab Republic (SAR), pharmacoeconomic study of antiretroviral therapy (ART) regimens ..." | ||
| Vol 15, No 2 (2022) | Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings | Abstract similar documents |
| M. V. Zhuravleva, S. N. Avdeev, Yu. V. Gagarina, T. V. Marin | ||
| "... Objective: evaluation of the pharmacoeconomic feasibility of using benralizumab in the form ..." | ||
| Vol 9, No 3 (2016) | EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS | Abstract similar documents |
| N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova | ||
| "... trials, to predict the probability of formulary inclusion, and to define socially acceptable price. ..." | ||
| Vol 15, No 1 (2022) | Efficacy of targeted drugs for the treatment of adults with moderate-to-severe plaque psoriasis in the Russian Federation: a systematic literature review update | Abstract similar documents |
| V. D. Sokolova, N. A. Sableva, V. V. Mladov, D. G. Tolkacheva | ||
| Vol 13, No 4 (2020) | Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia | Abstract similar documents |
| V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura | ||
| "... The study aimed to perform a pharmacoeconomic analysis of antimicrobial drugs (AMDs) prescribed ..." | ||
| Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation | Abstract similar documents |
| S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev | ||
| "... Objective – to conduct a pharmacoeconomic analysis of using omalizumab, mepolizumab and reslizumab ..." | ||
| Vol 18, No 1 (2025) | Pharmacoeconomic analysis of lanreotide and prolonged-release octreotide in first- and second-line therapy of acromegaly | Abstract similar documents |
| I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova, D. V. Kurkin | ||
| "... Background. Pharmacoeconomic aspects of somatostatin analogues remain an important topic ..." | ||
| Vol 7, No 2 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract similar documents |
| A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin | ||
| "... Abstract: we have performed the first-ever comparative pharmacoeconomic analysis in a Russian ..." | ||
| Vol 16, No 3 (2023) | Updated pharmacoeconomic analysis of atesolizumab efficiency compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy | Abstract similar documents |
| S. K. Zyryanov, I. N. Dyakov | ||
| "... Objective: to evaluate the pharmacoeconomic efficiency of atezolizumab (inhibitor of programmed ..." | ||
| Vol 5, No 3 (2012) | SEARCH OF INFORMATION IN PHARMACOECONOMIC RESEARCH | Abstract similar documents |
| R. I. Yagudina, I. V. Novikov, V. G. Serpik | ||
| "... in pharmacoeconomic studies. Review of methods of critical evaluation of research is also provided. ..." | ||
| Vol 6, No 1 (2013) | THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION | Abstract similar documents |
| A. Yu. Kulikov, Yu. L. Akimova | ||
| "... In this paper gradually showed features of the methodology for conducting of pharmacoeconomics ..." | ||
| Vol 17, No 1 (2024) | Pharmacoeconomic evaluation of first-line combination therapy with immunotherapy drugs and platinum-containing chemotherapy in adult patients with metastatic non-squamous non-small cell lung cancer | Abstract similar documents |
| S. К. Zyryanov, I. N. Dyakov | ||
| "... Objective: to evaluate the pharmacoeconomic efficacy of “atezolizumab + bevacizumab + paclitaxel ..." | ||
| Vol 6, No 1 (2013) | PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION | Abstract similar documents |
| R. I. Yagudina, I. Yu. Zinchuk | ||
| "... To provide pharmacoeconomic evaluation of diagnostics of tuberculosis infection (TI) with Allergen ..." | ||
| Vol 6, No 2 (2013) | PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION | Abstract similar documents |
| V. A. Chibilyaev, A. Yu. Kulikov, R. I. Yagudina | ||
| "... Comparative pharmacoeconomic analysis of two therapeutic strategy (the strategy A and the strategy ..." | ||
| Vol 17, No 4 (2024) | Economic effectiveness of fixed-dose combination of alogliptin and pioglitazone in diabetes mellitus treatment | Abstract similar documents |
| S. К. Zyryanov, I. N. Dyakov | ||
| "... and methods. A retrospective study involved pharmacoeconomic analysis, including cost-minimization analysis ..." | ||
| Vol 5, No 1 (2012) | PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING | Abstract similar documents |
| M. V. Protsenko, N. I. Koroleva | ||
| "... A properly conducted pharmacoeconomic study and its results are a new element in the body ..." | ||
| Vol 6, No 4 (2013) | Using indirect comparisons in pharmacoeconomic examination | Abstract similar documents |
| Yu. E. Balykina, A. S. Kolbin | ||
| "... obtained in the course of indirect comparisons to conducting pharmacoeconomic analysis are shown. ..." | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic aspects of COVID-19 treatment | Abstract similar documents |
| I. V. Rogova, E. A. Zhidkova, I. A. Popova, A. V. Zaborovskiy, K. G. Gurevich | ||
| "... in terms of pharmacoeconomic effectiveness. Different strategies for managing patients with the new ..." | ||
| Vol 5, No 1 (2012) | COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS | Abstract similar documents |
| R. I. Yagudina, I. Yu. Zinchuk, M. M. Litvinenko | ||
| Vol 6, No 4 (2013) | Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital | Abstract similar documents |
| A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
| "... for the first time in the Russian conditions the pharmacoeconomic analysis examined ..." | ||
| Vol 7, No 2 (2014) | CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM | Abstract similar documents |
| I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek | ||
| "... is the optimum pharmacoeconomic acceptability in patients with stable angina and high heart rate (70 beats per ..." | ||
| Vol 8, No 2 (2015) | PHARMACOECONOMIC STUDIES TREATMENT OF PATIENTS WITH INJURIES IN THE DEPARTMENT OF ANESTHESIOLOGY AND RESUSCITATION WITH METHODS ANALYSIS THE COST OF ILLNESS | Abstract similar documents |
| Anton Alexandrovich Kasatkin | ||
| "... The aim of the study was to conduct pharmacoeconomic analysis of treatment of patients with trauma ..." | ||
| Vol 8, No 2 (2015) | ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA | Abstract similar documents |
| Elamin H. Elbasha, Elena Aleksandrovna Pyadushkina, Maria Vladimirovna Avxentyeva, Alexander Gennadievich Tolkushin, Maxim Yurievich Frolov | ||
| "... of antiretroviral therapy, pharmacoeconomic analysis of "costs and benefits" was performed in accordance ..." | ||
| Vol 11, No 1 (2018) | CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation | Abstract similar documents |
| A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin | ||
| "... are not well studied. Aim.To evaluate the pharmacoeconomic benefits of CYP2D6 polymorphisms genotyping ..." | ||
| Vol 16, No 4 (2023) | Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer | Abstract similar documents |
| E. P. Kulikov, M. V. Shomova, D. S. Titov, A. N. Demko, M. A. Maistrenko | ||
| "... . According to the results of a pharmacoeconomic study, it is more economically profitable to detect SLN ..." | ||
| Vol 10, No 3 (2017) | Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients | Abstract similar documents |
| N. K. Mazina, P. V. Mazin | ||
| "... the pharmacoeconomic aspects of using enzalutamide, cabazitaxel and abiraterone for the second-line therapy of CRPC ..." | ||
| Vol 6, No 4 (2013) | Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis | Abstract similar documents |
| R. I. Yagudina, M. M. Murashko | ||
| "... the research work was conducted for the pharmacoeconomic evaluation and optimization of fluid ..." | ||
| Vol 6, No 3 (2013) | PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER | Abstract similar documents |
| R. I. Yagudina, I. Yu. Zinchuk | ||
| Vol 11, No 1 (2018) | Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia | Abstract similar documents |
| I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
| "... The aim: to provide a comprehensive pharmacoeconomic evaluation of the antipsychotic maintenance ..." | ||
| Vol 11, No 1 (2018) | Modeling microbial drug-resistance: from mathematics to pharmacoeconomics | Abstract similar documents |
| Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko | ||
| Vol 11, No 2 (2018) | Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia | Abstract similar documents |
| I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina | ||
| "... The aim: to provide a comprehensive pharmacoeconomic evaluation of the maintenance therapy ..." | ||
| Vol 14, No 2 (2021) | Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis | Abstract similar documents |
| N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova | ||
| "... and pharmacoeconomics to evaluate the widespread introduction of new anti-tuberculosis drugs (ATDs), taking into account ..." | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer | Abstract similar documents |
| Yu. Yu. Petukhova, E. V. Eliseeva, M. V. Volkov, O. N. Li, A. G. Petukhova | ||
| "... Objective: to perform a pharmacoeconomic evaluation of the effectiveness of therapies ..." | ||
| Vol 17, No 3 (2024) | Review of open libraries for pharmacoeconomic analysis in R environment | Abstract similar documents |
| I. A. Lackman, R. I. Sladkov, V. M. Timiryanova | ||
| "... pharmacoeconomic analysis. Material and methods. The selection of libraries used for pharmacoeconomic analysis ..." | ||
| Vol 5, No 1 (2012) | PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION | Abstract similar documents |
| R. Yagudina, A. Kulikov, B. Misikova | ||
| "... Pharmacoeconomic evaluation of treatment of the second and third lines of multiple myeloma ..." | ||
| Vol 5, No 2 (2012) | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES | Abstract similar documents |
| R. I. Yagudina, I. V. Sorokovikov | ||
| "... pharmacoeconomic cost-utility analysis – CUA is at third place by popularity (10% of studies ..." | ||
| Vol 5, No 3 (2012) | DEVELOPMENT OF A COMPUTER MODULE FOR FORECASTING AND ESTIMATING EFFICIENCY OF BASIC THERAPY OF MULTIPLE SCLEROSIS | Abstract similar documents |
| F. A. Khabirov, D. Kh. Shakirova, O. A. Dun, T. I. Khaibullin | ||
| "... the pharmacoeconomic evaluation of the rationality of the appointment and a forecast of efficiency of basic therapy ..." | ||
| 1 - 50 of 200 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
